
10x Genomics TXG
$ 15.77
2.01%
Quarterly report 2024-Q3
added 10-29-2024
10x Genomics ROCE Ratio 2011-2025 | TXG
Annual ROCE Ratio 10x Genomics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.8 | -20.84 | -6.39 | -72.27 | -5.63 | - | -34.37 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -5.63 | -72.27 | -29.22 |
Quarterly ROCE Ratio 10x Genomics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.78 | -35.03 | -35.74 | -27.19 | -22.52 | -22.59 | -21.28 | -15.21 | -17.2 | -10.46 | -4.66 | -13.49 | -20.33 | -24.35 | -16.85 | -19.02 | -12.35 | -9.49 | -5.35 | 1.43 | 10.39 | 12.85 | 6.79 | 6.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.85 | -35.74 | -13.65 |
ROCE Ratio of other stocks in the Health information services industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
19.24 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
-22.83 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-1.52 | - | - | $ 2.94 B | ||
|
Accolade
ACCD
|
-11.97 | - | 0.29 % | $ 206 M | ||
|
Castlight Health, Inc.
CSLT
|
-9.43 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
7.6 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
3.97 | - | - | $ 6.37 B | ||
|
Change Healthcare
CHNG
|
3.08 | - | - | $ 9.03 B | ||
|
Evolent Health
EVH
|
0.42 | $ 4.11 | -0.48 % | $ 385 M | ||
|
Health Catalyst
HCAT
|
-19.11 | $ 2.34 | -4.82 % | $ 141 M | ||
|
HealthStream
HSTM
|
5.92 | $ 24.4 | 0.95 % | $ 741 M | ||
|
iCAD
ICAD
|
-21.85 | - | - | $ 102 M | ||
|
Akerna Corp.
KERN
|
253.17 | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
3.86 | $ 96.06 | -0.75 % | $ 8.22 B | ||
|
OptimizeRx Corporation
OPRX
|
-20.86 | $ 13.18 | -1.35 % | $ 226 M | ||
|
American Well Corporation
AMWL
|
-71.38 | $ 4.68 | 1.3 % | $ 70.2 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
5.48 | - | -10.39 % | $ 886 M | ||
|
Progyny
PGNY
|
3.74 | $ 26.39 | -1.2 % | $ 2.26 B | ||
|
Premier
PINC
|
0.07 | $ 28.26 | - | $ 2.33 B | ||
|
MTBC
MTBC
|
18.32 | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
9.09 | $ 2.72 | -3.72 % | $ 1.05 B | ||
|
Schrödinger
SDGR
|
-49.66 | $ 18.41 | 1.99 % | $ 1.34 B | ||
|
Omnicell
OMCL
|
0.03 | $ 43.31 | -1.25 % | $ 1.99 B | ||
|
1Life Healthcare
ONEM
|
-14.09 | - | - | $ 3.37 B | ||
|
Phreesia
PHR
|
-54.28 | $ 16.68 | 2.71 % | $ 910 M | ||
|
So-Young International
SY
|
-31.46 | $ 2.92 | -5.66 % | $ 232 M | ||
|
Signify Health
SGFY
|
1.16 | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
42.02 | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
22.77 | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
2.97 | - | - | $ 1.6 B | ||
|
Veeva Systems
VEEV
|
9.24 | $ 219.17 | -1.81 % | $ 35.2 B | ||
|
Zhongchao
ZCMD
|
-0.98 | $ 0.58 | -3.18 % | $ 3.02 M | ||
|
Streamline Health Solutions
STRM
|
-64.14 | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
-68.47 | $ 7.36 | -2.65 % | $ 1.26 B | ||
|
Tabula Rasa HealthCare
TRHC
|
120.94 | - | - | $ 255 M | ||
|
SCWorx Corp.
WORX
|
-27.93 | $ 0.21 | 5.86 % | $ 306 K |